NCT06237959 is a NA clinical trial of Keranat™ in Hair Damage, sponsored by Nutracore.

Who is sponsoring NCT06237959?

NCT06237959 is sponsored by Nutracore.

What drugs are being tested in NCT06237959?

Interventions in NCT06237959: Keranat™, placebo.

What condition does NCT06237959 study?

NCT06237959 studies Hair Damage.

Is NCT06237959 still recruiting?

NCT06237959 is currently completed. Last updated 2 February 2024.

Last reviewed 2024-02-02 · How we verify

NCT06237959

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Evaluate the Efficacy and Safety of Proso Millet and Wheat Extract(Keranat™) on Hair Health

Completed NA Last updated 2 February 2024

What this trial tests

NA trial testing Keranat™ in Hair Damage in 100 participants. Completed in 11 December 2023.

Timeline

2 November 2022

Primary endpoint
12 June 2023

11 December 2023

Quick facts

Lead sponsor	Nutracore
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	prevention
Enrollment	100
Start date	2 November 2022
Primary completion	12 June 2023
Estimated completion	11 December 2023
Sites	1 location across South Korea

Drugs / interventions tested

Keranat™
placebo

Conditions studied

Hair Damage — all drugs for Hair Damage →

Sponsor

Nutracore

Who can join

Adults 19 to 60, any sex, with Hair Damage. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this randomized, double-blind, placebo-controlled study will be to evaluate whether the daily intake of Keranat™ for 24 weeks can promote the gloss and elasticity of hairs, improve their density and strength, and reduce hair loss.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06237959 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Nutracore
Last refreshed: 2 February 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06237959.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing